首页> 外文期刊>Nature >Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
【24h】

Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers

机译:Wnt驱动的乳腺癌中通过协同亚克隆维持的肿瘤细胞异质性

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer genome sequencing studies indicate that a single breast cancer typically harbours multiple genetically distinct subclones. As carcinogenesis involves a breakdown in the cell-cell cooperation that normally maintains epithelial tissue architecture, individual subclones within a malignant microenvironment are commonly depicted as self-interested competitors. Alternatively, breast cancer subclones might interact cooperatively to gain a selective growth advantage in some cases. Although interclonal cooperation has been shown to drive tumorigenesis in fruitfly models, definitive evidence for functional cooperation between epithelial tumour cell subclones in mammals is lacking. Here we use mouse models of breast cancer to show that interclonal cooperation can be essential for tumour maintenance. Aberrant expression of the secreted signalling molecule Wntl generates mixed-lineage mammary tumours composed of basal and luminal tumour cell subtypes, which purportedly derive from a bipotent malignant progenitor cell residing atop a tumour cell hierarchy. Using somatic Hras mutations as clonal markers, we show that some Wnt tumours indeed conform to a hierarchical configuration, but that others unexpectedly harbour genetically distinct basal Hras mutant and luminal ifras wild-type subclones. Both subclones are required for efficient tumour propagation, which strictly depends on lumin-ally produced Wntl. When biclonal tumours were challenged with Wnt withdrawal to simulate targeted therapy, analysis of tumour regression and relapse revealed that basal subclones recruit heterologous Wnt-producing cells to restore tumour growth. Alternatively, in the absence of a substitute Wnt source, the original subclones often evolve to rescue Wnt pathway activation and drive relapse, either by restoring cooperation or by switching to a defector strategy. Uncovering similar modes of interclonal cooperation in human cancers may inform efforts aimed at eradicating tumour cell communities.%本期封面所示为来自表达一个世系标记(绿色)的供体小鼠(红色)的基底乳腺肿瘤细胞与来自主体的上皮细胞相互混杂。左边伸长的乳腺导管在没有被来自供体的肿瘤亚克隆滲透的情况下保留了正常的双层架构。肿瘤经常表现出复杂的亚克隆组织。在由Wnt信号作用引发的乳腺癌的一个小鼠模型中,Allison Cleary等人发现,有些肿瘤是双克隆的,即由具有截然不同基因改变的基底克隆和管腔克隆组成。这些克隆相互合作来维持肿瘤生长,后者取决于管腔细胞对Wnt的分泌。当Wnt的生成被阻断时,携带Hras突变的基底细胞会招募其他能生成Wnt的细胞来恢复肿瘤生长,否则原始克隆当中的一个可能会获得激活该通道的其他手段。这些发现揭示了异质肿瘤内的复杂细胞相互作用会怎样改变治疗结果。
机译:癌症基因组测序研究表明,单个乳腺癌通常具有多个遗传上不同的亚克隆。由于致癌作用涉及正常维持上皮组织结构的细胞-细胞相互作用的破坏,因此通常将恶性微环境内的单个亚克隆描述为自私竞争者。或者,在某些情况下,乳腺癌亚克隆可能协同作用以获得选择性的生长优势。尽管在果蝇模型中已显示出克隆间合作可促进肿瘤发生,但缺乏关于哺乳动物上皮肿瘤细胞亚克隆之间功能性合作的明确证据。在这里,我们使用乳腺癌的小鼠模型来证明克隆间的合作对于维持肿瘤至关重要。分泌的信号传导分子Wnt1的异常表达产生了由基底和管腔肿瘤细胞亚型组成的混合谱系乳腺肿瘤,据称这些肿瘤亚型起源于位于肿瘤细胞层次之上的双能恶性祖细胞。使用体细胞Hras突变作为克隆标记,我们表明,某些Wnt肿瘤确实符合分级结构,但其他突变体出乎意料地具有遗传上不同的基础Hras突变体和管腔ifras野生型亚克隆。这两个亚克隆都是有效肿瘤扩散所必需的,这严格取决于发光产生的Wnt1。当用Wnt撤离攻击双链体肿瘤以模拟靶向治疗时,对肿瘤消退和复发的分析表明,基础亚克隆募集了异源Wnt产生细胞来恢复肿瘤生长。或者,在没有替代性Wnt来源的情况下,原始亚克隆通常会通过恢复合作或切换至叛逃者策略来进化以挽救Wnt途径的活化并驱动复发。发现人类癌症中相似的克隆间合作模式可能有助于旨在消除肿瘤细胞群落的努力。%本期封面插图为来自表达一个世系标记(绿色)的供体小鼠。的上皮细胞相互分散。左延长的乳腺导管在没有被来自供体的肿瘤亚克隆渗透的情况下保留了正常的双层架构。肿瘤经常表现出复杂的亚克隆组织。在由Wnt信号作用引发这些克隆相互的一个小鼠模型中,Allison Cleary等人发现,有些肿瘤是双克隆的,即由具有截然不同基因改变的基底克隆和管腔克隆组成。当Wnt的生成被中断时,携带Hras突变的基底细胞会招募其他能生成Wnt的细胞来恢复肿瘤生长,否则原始克隆当中的一个可能会获得激活该通道。这些发现揭示了异质肿瘤内部的复杂细胞相互作用会怎样改变治疗结果。

著录项

  • 来源
    《Nature》 |2014年第7494期|113-117A1|共6页
  • 作者单位

    Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA,Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, Hershey, Pennsylvania 17033, USA;

    Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA,Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, Hershey, Pennsylvania 17033, USA;

    Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA,Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, Hershey, Pennsylvania 17033, USA;

    Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA,Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, Hershey, Pennsylvania 17033, USA,Departmentof Medicine (Hematology/Oncology), Pennsylvania State University College of Medicine, Hershey, Hershey, Pennsylvania 17033, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号